Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 7c
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.97), $0.07 better than the analyst estimate of ($2.04).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.97), $0.07 better than the analyst estimate of ($2.04).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.